4335 Nqo1 FMN-binding domain-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 30 | 8.7 | 3.44× | q < 0.0001 | |
| Organic oxygen compounds | 1 | 6.3 | 0.16× | q = 0.02 | |
| Homogeneous non-metal compounds | 1 | 6.8 | 0.15× | q = 0.02 | |
| Homogeneous metal compounds | 2 | 15.5 | 0.13× | q < 0.0001 | |
| Organoheterocyclic compounds | 2 | 4.9 | 0.41× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03247 | FMN | Flavin mononucleotide | 304 |
| DB00157 | NAI | NADH | 94 |
| DB14128 | NAD | Nadide | 15 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 8 |
| DB00140 | RBF | Riboflavin | 2 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 2 |
| DB04447 | DTT | 1,4-Dithiothreitol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SF4 | IRON/SULFUR CLUSTER | 455 |
| FMN | FLAVIN MONONUCLEOTIDE | 448 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 106 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 65 |
| NAmetal | SODIUM ION | 59 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 30 |
| FNR | 1-DEOXY-1-(7,8-DIMETHYL-2,4-DIOXO-3,4-DIHYDRO-2H-BENZO[G]PTERIDIN-1-ID-10(5H)-YL)-5-O-PHOSPHONATO-D-RIBITOL | 22 |
| CL | CHLORIDE ION | 20 |
| MPO | 3[N-MORPHOLINO]PROPANE SULFONIC ACID | 16 |
| A3D | 3-ACETYLPYRIDINE ADENINE DINUCLEOTIDE | 4 |
| AP0 | ACETYL PYRIDINE ADENINE DINUCLEOTIDE, REDUCED | 4 |
| MGmetal | MAGNESIUM ION | 4 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 2 |
| L3W | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[[(1~{E},3~{Z})-5-azanyl-4-oxidanyl-5-oxidanylidene-penta-1,3-dienyl]-methanoyl-amino]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | 2 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 2 |
| DTT | 2,3-DIHYDROXY-1,4-DITHIOBUTANE | 1 |
| Kmetal | POTASSIUM ION | 1 |